Bryan’s practice focuses on complex commercial litigation and counseling, primarily in the antitrust area. A partner in the Firm’s Global Antitrust Practice based in New York, he represents clients in the pharmaceutical, financial services and petroleum sectors. Notable recent clients include Pfizer, Allergan, Boehringer Ingelheim, Experian, Novartis, OPEC and Warner Chilcott. Bryan’s knowledge and experience span a wide range of issues, including "reverse payment" settlements of patent disputes, product innovation and product retirement (so-called "product hopping"), price-fixing, fraudulent procurement of patents and other misconduct before the US Patent & Trademark Office, sham litigation, sham petitioning of the FDA, product bundling, and other antitrust theories. Bryan is a regular contributor to Antitrust Law Developments, and a member of the Antitrust Section of the American Bar Association.

This author’s articles

2020 Awards

Send a message